Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forrest

Showing results (341-350 of 374) with videos related to

Pageof 38
Sort By:
Physical Review. E|August 31, 2016
Core conditions for alpha heating attained in direct-drive inertial confinement fusionA Bose, K M Woo, R Betti, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agentsT Biftu, D D Feng, G B Liang, et al.
Physical Review. E|December 23, 2025
Observation of kinetic mix enhancement in thin-shell OMEGA implosionsB L Reichelt, M Gatu Johnson, J H Kunimune, et al.
Physical Review Letters|August 16, 2021
Direct Measurements of DT Fuel Preheat from Hot Electrons in Direct-Drive Inertial Confinement FusionA R Christopherson, R Betti, C J Forrest, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamidesE M Naylor, E R Parmee, V J Colandrea, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamidesE R Parmee, E M Naylor, L Perkins, et al.
Physical Review Letters|September 22, 2023
Effects of Laser Bandwidth in Direct-Drive High-Performance DT-Layered Implosions on the OMEGA LaserD Patel, J P Knauer, D Cao, et al.
Journal of Medicinal Chemistry|April 30, 2004
Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activityAmjad Ali, Christopher F Thompson, James M Balkovec, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profilesC C Chan, S Boyce, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
A potent and selective indole N-type calcium channel (Ca(v)2.2) blocker for the treatment of painSriram Tyagarajan, Prasun K Chakravarty, Min Park, et al.
Pageof 38

Showing results (341-350 of 374) with videos related to

Sort By:
Pageof 38
Physical Review. E|August 31, 2016
Core conditions for alpha heating attained in direct-drive inertial confinement fusionA Bose, K M Woo, R Betti, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agentsT Biftu, D D Feng, G B Liang, et al.
Physical Review. E|December 23, 2025
Observation of kinetic mix enhancement in thin-shell OMEGA implosionsB L Reichelt, M Gatu Johnson, J H Kunimune, et al.
Physical Review Letters|August 16, 2021
Direct Measurements of DT Fuel Preheat from Hot Electrons in Direct-Drive Inertial Confinement FusionA R Christopherson, R Betti, C J Forrest, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamidesE M Naylor, E R Parmee, V J Colandrea, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 1999
Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamidesE R Parmee, E M Naylor, L Perkins, et al.
Physical Review Letters|September 22, 2023
Effects of Laser Bandwidth in Direct-Drive High-Performance DT-Layered Implosions on the OMEGA LaserD Patel, J P Knauer, D Cao, et al.
Journal of Medicinal Chemistry|April 30, 2004
Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activityAmjad Ali, Christopher F Thompson, James M Balkovec, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profilesC C Chan, S Boyce, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
A potent and selective indole N-type calcium channel (Ca(v)2.2) blocker for the treatment of painSriram Tyagarajan, Prasun K Chakravarty, Min Park, et al.
Pageof 38